+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sepsis Diagnostic Market - Global Forecast 2026-2032- Product Image
Sepsis Diagnostic Market - Global Forecast 2026-2032- Product Image
Sale

Sepsis Diagnostic Market - Global Forecast 2026-2032

  • Report

  • 181 Pages
  • August 2026
  • Region: Global
  • 360iResearch™
  • ID: 5311190
UP TO OFF until Jan 01st 2027
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.
The Sepsis Diagnostic Market is projected to reach USD 1.07 Billion in 2026. It is expected to continue growing at a CAGR of 8.35%, reaching USD 1.74 Billion by 2032.

Sepsis diagnostics are becoming a core priority for hospitals, laboratories, and health systems because sepsis remains one of the most time-sensitive and high-mortality conditions in acute care. The World Health Organization estimates that sepsis affected approximately 49 million people and was associated with about 11 million deaths worldwide in 2017, representing nearly one-fifth of global deaths. In the United States, the CDC reports that at least 1.7 million adults develop sepsis annually, with roughly 350,000 deaths during hospitalization or discharge to hospice.

The sepsis diagnostic landscape spans blood culture, lactate testing, procalcitonin, C-reactive protein, host-response assays, molecular diagnostics, multiplex syndromic panels, antimicrobial susceptibility testing, and clinical decision support tools. Demand is rising as emergency departments, intensive care units, and microbiology laboratories seek faster pathogen identification, earlier risk stratification, and more precise antimicrobial stewardship. This makes accurate, rapid, and workflow-ready sepsis testing essential for improving treatment decisions and reducing avoidable delays.

Transformative Shifts in Sepsis Diagnostics

The sepsis diagnostic landscape is shifting from culture-dependent workflows toward integrated, time-sensitive diagnostic pathways. Conventional blood culture remains essential for pathogen recovery and antimicrobial susceptibility testing, but its turnaround time can delay targeted therapy. Rapid molecular diagnostics, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry, host immune-response signatures, and automated laboratory platforms are increasingly used to shorten the interval from suspicion to actionable results.

A second transformation is occurring at the care-delivery level. Sepsis screening is moving beyond the ICU into emergency departments, medical wards, ambulatory escalation pathways, and remote triage programs. Hospitals are prioritizing diagnostic solutions that combine clinical scoring, laboratory biomarkers, electronic health record alerts, and stewardship protocols to reduce inappropriate antibiotic use while supporting early intervention for high-risk patients. The shift is also reinforcing the need for interoperability between laboratory information systems, electronic health records, and point-of-care workflows.

Cumulative Impact of Artificial Intelligence

Artificial intelligence is having a cumulative impact on sepsis diagnostics by improving risk prediction, workflow prioritization, and clinical decision support. AI-enabled models can analyze electronic health record data, vital signs, laboratory trends, medication history, comorbidities, and microbiology signals to flag deterioration earlier than manual review alone. The strongest applications are not stand-alone replacements for clinicians but assistive systems embedded into validated sepsis protocols.

The opportunity is tied to governance and evidence. Hospitals are demanding transparent model performance, bias monitoring, local validation, human oversight, and integration with laboratory information systems. AI can also support diagnostic stewardship by helping clinicians decide when to order blood cultures, lactate, procalcitonin, molecular panels, or repeat testing, thereby aligning rapid sepsis diagnostics with cost control and antimicrobial stewardship. As regulatory expectations for clinical software mature, explainability, auditability, and real-world monitoring are becoming essential adoption criteria.

Key Regional Insights: Sepsis Diagnostic Adoption

Asia-Pacific is a major sepsis diagnostic adoption region due to expanding hospital capacity, large patient populations, and rising use of automated microbiology and molecular testing in China, India, Japan, South Korea, and Australia. The region’s infectious disease burden, growing intensive care infrastructure, and increasing focus on antimicrobial resistance are strengthening demand for rapid pathogen identification and biomarker-based risk assessment. North America remains a mature innovation hub, supported by hospital quality initiatives, CDC sepsis awareness programs, FDA-regulated diagnostic pathways, and strong adoption of rapid pathogen identification technologies across emergency departments, ICUs, and centralized laboratories.

Europe benefits from coordinated antimicrobial resistance strategies, advanced laboratory networks, and strong demand for evidence-based diagnostic stewardship under rigorous in vitro diagnostic and clinical performance expectations. Latin America is expanding access to blood culture automation and critical care diagnostics, with Brazil and Mexico serving as important adoption centers as tertiary hospitals modernize microbiology capabilities. The Middle East is investing in tertiary care infrastructure, digital health, and laboratory modernization, particularly in urban hospital networks, while Africa faces the highest need for scalable, affordable sepsis diagnostics that can operate across resource-variable settings where timely blood culture access, trained personnel, and laboratory connectivity remain uneven.

Key Group Insights Across Strategic Economies

ASEAN markets are advancing sepsis diagnostics through investment in hospital laboratories, infectious disease surveillance, and critical care capacity, although access remains uneven between urban referral centers and rural facilities. The GCC is accelerating uptake through premium hospital systems, digital health programs, and centralized laboratory networks, particularly where sepsis management is integrated into emergency and intensive care pathways. These group-level dynamics highlight the importance of diagnostics that are scalable, interoperable, and adaptable to different levels of laboratory maturity.

The European Union is shaped by regulatory rigor, antimicrobial resistance policy, cross-border health technology assessment, and growing emphasis on diagnostic stewardship within hospital infection management. BRICS countries represent a major clinical-volume opportunity because China, India, Brazil, Russia, and South Africa combine large patient pools with growing demand for cost-effective rapid diagnostics and more resilient laboratory systems. G7 markets lead in clinical validation, reimbursement sophistication, quality-based care pathways, and AI-enabled decision support, while NATO member countries increasingly emphasize resilient diagnostics, infectious disease preparedness, supply chain continuity, and hospital readiness for emerging biological threats.

Key Country Insights in Sepsis Diagnostics

The United States leads adoption of sepsis diagnostic innovation due to high sepsis burden, hospital quality metrics, antimicrobial stewardship requirements, and strong demand for rapid molecular testing and AI clinical decision support. Canada emphasizes standardized care pathways, laboratory quality, and equitable access across provincial health systems, while Mexico and Brazil are expanding hospital-based diagnostics amid rising critical care needs and investment in tertiary care infrastructure. The United Kingdom, Germany, France, Italy, and Spain demonstrate strong demand for antimicrobial stewardship-aligned diagnostics, with Germany and France supported by advanced laboratory infrastructure and the United Kingdom emphasizing protocolized sepsis recognition across acute care settings.

Russia maintains demand for hospital microbiology modernization and broader access to timely pathogen identification, while China and India are among the most important sepsis diagnostic adoption markets due to scale, infectious disease burden, expanding tertiary care, and growing laboratory automation. Japan, Australia, and South Korea show strong adoption potential for automated platforms, rapid pathogen identification, host-response testing, and digital sepsis surveillance, supported by sophisticated hospital systems, robust diagnostic quality standards, and aging populations that elevate sepsis risk. Across these countries, adoption is increasingly influenced by evidence of clinical utility, workflow integration, and the ability to support targeted antimicrobial therapy.

Actionable Recommendations for Industry Leaders

Industry leaders should prioritize clinically validated solutions that reduce time to actionable results rather than simply adding test volume. The strongest strategies combine blood culture optimization, rapid molecular diagnostics, biomarker testing, antimicrobial susceptibility workflows, and AI-enabled triage into practical sepsis pathways that emergency physicians, intensivists, infectious disease specialists, and laboratory teams can trust. Solutions should be designed for integration with existing laboratory information systems, electronic health records, and antimicrobial stewardship programs.

Commercial success will depend on demonstrating measurable value: earlier appropriate therapy, reduced unnecessary broad-spectrum antibiotic use, shorter length of stay, improved laboratory productivity, and alignment with sepsis quality programs. Companies should invest in regional evidence generation, reimbursement strategy, cybersecurity for connected diagnostics, user training, and partnerships with hospitals that can validate real-world performance across diverse patient populations. Leaders should also adapt product configurations for resource-variable settings, including simplified workflows, robust sample handling, and clear clinical interpretation.

Research Methodology

This executive summary is developed using a structured secondary-research methodology grounded in verified public health, regulatory, clinical, and market-relevant sources. Key inputs include WHO and CDC sepsis burden data, peer-reviewed literature on sepsis biomarkers and molecular diagnostics, antimicrobial resistance policy documents, regulatory guidance for in vitro diagnostics and software as a medical device, and publicly available hospital quality initiatives.

Insights are synthesized through triangulation across disease burden, technology adoption, laboratory workflow, regional healthcare infrastructure, regulatory maturity, and commercial readiness. Emphasis is placed on evidence-backed interpretation rather than speculative claims, with attention to diagnostic utility, implementation constraints, and the practical requirements of clinicians, microbiologists, payers, and health system decision-makers. The analysis avoids market sizing, share estimates, and forecasts, focusing instead on verified adoption drivers and operational implications.

Conclusion

Sepsis diagnostics are entering a more integrated era defined by speed, accuracy, stewardship, and clinical workflow alignment. While blood culture remains foundational, the field is increasingly shaped by molecular diagnostics, host-response biomarkers, automated microbiology, lactate and procalcitonin testing, antimicrobial susceptibility workflows, and AI-enabled decision support that can help identify high-risk patients earlier.

The next phase of adoption will favor organizations that prove clinical value in real-world settings and adapt solutions to regional healthcare realities. As sepsis continues to impose a major global mortality and economic burden, reliable diagnostics that accelerate evidence-based treatment will remain essential to patient outcomes, hospital performance, antimicrobial resistance control, and health system resilience.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Definition
1.3. Market Segmentation & Coverage
1.4. Years Considered for the Study
1.5. Currency Considered for the Study
1.6. Language Considered for the Study
1.7. Key Stakeholders
2. Research Methodology
2.1. Introduction
2.2. Research Design
2.2.1. Primary Research
2.2.2. Secondary Research
2.3. Research Framework
2.3.1. Qualitative Analysis
2.3.2. Quantitative Analysis
2.4. Market Size Estimation
2.4.1. Top-Down Approach
2.4.2. Bottom-Up Approach
2.5. Data Triangulation
2.6. Research Outcomes
2.7. Research Assumptions
2.8. Research Limitations
3. Executive Summary
3.1. Introduction
3.2. CXO Perspective
3.3. Market Size & Growth Trends
3.4. New Revenue Opportunities
3.5. Next-Generation Business Models
3.6. Industry Roadmap
4. Market Overview
4.1. Introduction
4.2. Industry Ecosystem & Value Chain Analysis
4.2.1. Supply-Side Analysis
4.2.2. Demand-Side Analysis
4.2.3. Stakeholder Analysis
4.3. Market Dynamics
4.3.1. Key Drivers
4.3.2. Key Restraints
4.3.3. Key Opportunities
4.3.4. Key Challenges
4.4. Porter’s Five Forces Analysis
4.5. PESTLE Analysis
4.6. Market Outlook
4.6.1. Near-Term Market Outlook (0-2 Years)
4.6.2. Medium-Term Market Outlook (3-5 Years)
4.6.3. Long-Term Market Outlook (5-10 Years)
4.7. Go-to-Market Strategy
5. Market Insights
5.1. Consumer Insights & End-User Perspective
5.2. Consumer Experience Benchmarking
5.3. Opportunity Mapping
5.4. Distribution Channel Analysis
5.5. Pricing Trend Analysis
5.6. Regulatory Compliance & Standards Framework
5.7. ESG & Sustainability Analysis
5.8. Disruption & Risk Scenarios
5.9. Return on Investment & Cost-Benefit Analysis
6. Cumulative Impact of Artificial Intelligence 2026
7. Sepsis Diagnostic Market, by Product Type
7.1. Introduction
7.2. Instruments
7.2.1. Analyzers
7.2.2. Point-Of-Care Devices
7.3. Reagents & Kits
7.3.1. Biomarker Kits
7.3.2. Culture Media
7.4. Software & Services
7.4.1. Consulting Services
7.4.2. Data Management Software
8. Sepsis Diagnostic Market, by Technology
8.1. Introduction
8.2. ELISA
8.2.1. Competitive ELISA
8.2.2. Sandwich ELISA
8.3. Flow Cytometry
8.3.1. Conventional Flow Cytometry
8.3.2. Imaging Flow Cytometry
8.4. NGS
8.4.1. Targeted Sequencing
8.4.2. Whole Genome Sequencing
8.5. PCR
8.5.1. Multiplex PCR
8.5.2. Real-Time PCR
9. Sepsis Diagnostic Market, by End User
9.1. Introduction
9.2. Ambulatory Care Centers
9.2.1. Clinics
9.2.2. Outpatient Centers
9.3. Diagnostic Laboratories
9.3.1. Clinical Laboratories
9.3.2. Reference Laboratories
9.4. Hospitals
9.4.1. General Hospitals
9.4.2. Tertiary Care Hospitals
10. Sepsis Diagnostic Market, by Distribution Channel
10.1. Introduction
10.2. Direct
10.3. Indirect
10.3.1. Distributors
10.3.2. E-Commerce
11. Sepsis Diagnostic Market, by Region
11.1. Asia-Pacific
11.2. Europe
11.3. North America
11.4. Latin America
11.5. Africa
11.6. Middle East
12. Sepsis Diagnostic Market, by Group
12.1. NATO
12.2. G7
12.3. BRICS
12.4. European Union
12.5. ASEAN
12.6. GCC
13. Sepsis Diagnostic Market, by Country
13.1. China
13.2. United States
13.3. Japan
13.4. India
13.5. Germany
13.6. United Kingdom
13.7. Australia
13.8. France
13.9. South Korea
13.10. Italy
13.11. Canada
13.12. Russia
13.13. Brazil
13.14. Mexico
13.15. Spain
14. Competitive Landscape
14.1. Market Share Analysis, 2025
14.2. FPNV Positioning Matrix, 2025
14.3. Market Concentration Analysis, 2025
14.3.1. Concentration Ratio (CR)
14.3.2. Herfindahl Hirschman Index (HHI)
14.4. Recent Developments & Impact Analysis, 2025
14.5. Product Portfolio Analysis, 2025
14.6. Benchmarking Analysis, 2025
15. Company Profiles
15.1. Abbott Laboratories
15.2. Alifax S.r.l.
15.3. Beckman Coulter, Inc.
15.4. Becton, Dickinson and Company
15.5. bioMérieux SA
15.6. Boditech Med Inc.
15.7. Bruker Corporation
15.8. CytoSorbents Corporation
15.9. DiaSorin S.p.A.
15.10. EKF Diagnostics
15.11. F. Hoffmann-La Roche AG
15.12. Immunexpress Inc.
15.13. Koninklijke Philips N.V.
15.14. McKesson Corporation
15.15. Merck KGaA
15.16. Molzym GmbH & Co. KG
15.17. Nanomix Inc.
15.18. Oracle Corporation
15.19. QIAGEN N.V.
15.20. Response Biomedical Corporation
15.21. Seegene Inc.
15.22. Siemens Healthineers
15.23. T2 Biosystems
15.24. Thermo Fisher Scientific, Inc.
15.25. Wolters Kluwer N.V.
List of Figures
FIGURE 1. GLOBAL SEPSIS DIAGNOSTIC MARKET, YEARS CONSIDERED FOR THE STUDY
FIGURE 2. GLOBAL SEPSIS DIAGNOSTIC MARKET, RESEARCH DESIGN
FIGURE 3. GLOBAL SEPSIS DIAGNOSTIC MARKET, RESEARCH FRAMEWORK
FIGURE 4. GLOBAL SEPSIS DIAGNOSTIC MARKET, DATA TRIANGULATION
FIGURE 5. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, 2024-2032 (USD MILLION)
FIGURE 6. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2032 (%)
FIGURE 7. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 8. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025 VS 2032 (%)
FIGURE 9. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 10. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2025 VS 2032 (%)
FIGURE 11. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 12. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2032 (%)
FIGURE 13. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 14. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2025 VS 2032 (%)
FIGURE 15. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 16. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY GROUP, 2025 VS 2032 (%)
FIGURE 17. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 18. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2025 VS 2032 (%)
FIGURE 19. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
FIGURE 20. GLOBAL SEPSIS DIAGNOSTIC MARKET SHARE, BY KEY PLAYER, 2025
FIGURE 21. GLOBAL SEPSIS DIAGNOSTIC MARKET, FPNV POSITIONING MATRIX, BY KEY PLAYER, 2025
List of Tables
TABLE 1. GLOBAL SEPSIS DIAGNOSTIC MARKET SEGMENTATION & COVERAGE
TABLE 2. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 3. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 4. GLOBAL INSTRUMENTS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 5. GLOBAL INSTRUMENTS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 6. GLOBAL INSTRUMENTS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 7. GLOBAL ANALYZERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 8. GLOBAL ANALYZERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 9. GLOBAL ANALYZERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 10. GLOBAL POINT-OF-CARE DEVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 11. GLOBAL POINT-OF-CARE DEVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 12. GLOBAL POINT-OF-CARE DEVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 13. GLOBAL REAGENTS & KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 14. GLOBAL REAGENTS & KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 15. GLOBAL REAGENTS & KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 16. GLOBAL BIOMARKER KITS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 17. GLOBAL BIOMARKER KITS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 18. GLOBAL BIOMARKER KITS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 19. GLOBAL CULTURE MEDIA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 20. GLOBAL CULTURE MEDIA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 21. GLOBAL CULTURE MEDIA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 22. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 23. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 24. GLOBAL SOFTWARE & SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 25. GLOBAL CONSULTING SERVICES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 26. GLOBAL CONSULTING SERVICES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 27. GLOBAL CONSULTING SERVICES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 28. GLOBAL DATA MANAGEMENT SOFTWARE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 29. GLOBAL DATA MANAGEMENT SOFTWARE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 30. GLOBAL DATA MANAGEMENT SOFTWARE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 31. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 32. GLOBAL ELISA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 33. GLOBAL ELISA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 34. GLOBAL ELISA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 35. GLOBAL COMPETITIVE ELISA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 36. GLOBAL COMPETITIVE ELISA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 37. GLOBAL COMPETITIVE ELISA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 38. GLOBAL SANDWICH ELISA MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 39. GLOBAL SANDWICH ELISA MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 40. GLOBAL SANDWICH ELISA MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 41. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 42. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 43. GLOBAL FLOW CYTOMETRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 44. GLOBAL CONVENTIONAL FLOW CYTOMETRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 45. GLOBAL CONVENTIONAL FLOW CYTOMETRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 46. GLOBAL CONVENTIONAL FLOW CYTOMETRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 47. GLOBAL IMAGING FLOW CYTOMETRY MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 48. GLOBAL IMAGING FLOW CYTOMETRY MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 49. GLOBAL IMAGING FLOW CYTOMETRY MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 50. GLOBAL NGS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 51. GLOBAL NGS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 52. GLOBAL NGS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 53. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 54. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 55. GLOBAL TARGETED SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 56. GLOBAL WHOLE GENOME SEQUENCING MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 57. GLOBAL WHOLE GENOME SEQUENCING MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 58. GLOBAL WHOLE GENOME SEQUENCING MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 59. GLOBAL PCR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 60. GLOBAL PCR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 61. GLOBAL PCR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 62. GLOBAL MULTIPLEX PCR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 63. GLOBAL MULTIPLEX PCR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 64. GLOBAL MULTIPLEX PCR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 65. GLOBAL REAL-TIME PCR MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 66. GLOBAL REAL-TIME PCR MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 67. GLOBAL REAL-TIME PCR MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 68. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 69. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 70. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 71. GLOBAL AMBULATORY CARE CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 72. GLOBAL CLINICS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 73. GLOBAL CLINICS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 74. GLOBAL CLINICS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 75. GLOBAL OUTPATIENT CENTERS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 76. GLOBAL OUTPATIENT CENTERS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 77. GLOBAL OUTPATIENT CENTERS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 78. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 79. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 80. GLOBAL DIAGNOSTIC LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 81. GLOBAL CLINICAL LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 82. GLOBAL CLINICAL LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 83. GLOBAL CLINICAL LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 84. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 85. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 86. GLOBAL REFERENCE LABORATORIES MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 87. GLOBAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 88. GLOBAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 89. GLOBAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 90. GLOBAL GENERAL HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 91. GLOBAL GENERAL HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 92. GLOBAL GENERAL HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 93. GLOBAL TERTIARY CARE HOSPITALS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 94. GLOBAL TERTIARY CARE HOSPITALS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 95. GLOBAL TERTIARY CARE HOSPITALS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 96. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 97. GLOBAL DIRECT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 98. GLOBAL DIRECT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 99. GLOBAL DIRECT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 100. GLOBAL INDIRECT MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 101. GLOBAL INDIRECT MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 102. GLOBAL INDIRECT MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 103. GLOBAL DISTRIBUTORS MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 104. GLOBAL DISTRIBUTORS MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 105. GLOBAL DISTRIBUTORS MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 106. GLOBAL E-COMMERCE MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 107. GLOBAL E-COMMERCE MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 108. GLOBAL E-COMMERCE MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 109. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 110. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 111. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 112. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 113. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 114. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 115. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 116. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2017-2032 (USD MILLION)
TABLE 117. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 118. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2017-2032 (USD MILLION)
TABLE 119. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2017-2032 (USD MILLION)
TABLE 120. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 121. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 122. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 123. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 124. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 125. ASIA-PACIFIC SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2017-2032 (USD MILLION)
TABLE 126. EUROPE SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 127. EUROPE SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 128. EUROPE SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 129. EUROPE SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 130. EUROPE SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 131. EUROPE SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 132. EUROPE SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2017-2032 (USD MILLION)
TABLE 133. EUROPE SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 134. EUROPE SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2017-2032 (USD MILLION)
TABLE 135. EUROPE SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2017-2032 (USD MILLION)
TABLE 136. EUROPE SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 137. EUROPE SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 138. EUROPE SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 139. EUROPE SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 140. EUROPE SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 141. EUROPE SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2017-2032 (USD MILLION)
TABLE 142. NORTH AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 143. NORTH AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 144. NORTH AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 145. NORTH AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 146. NORTH AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 147. NORTH AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 148. NORTH AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2017-2032 (USD MILLION)
TABLE 149. NORTH AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 150. NORTH AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2017-2032 (USD MILLION)
TABLE 151. NORTH AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2017-2032 (USD MILLION)
TABLE 152. NORTH AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 153. NORTH AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 154. NORTH AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 155. NORTH AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 156. NORTH AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 157. NORTH AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2017-2032 (USD MILLION)
TABLE 158. LATIN AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 159. LATIN AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 160. LATIN AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 161. LATIN AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 162. LATIN AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 163. LATIN AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 164. LATIN AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2017-2032 (USD MILLION)
TABLE 165. LATIN AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 166. LATIN AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2017-2032 (USD MILLION)
TABLE 167. LATIN AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2017-2032 (USD MILLION)
TABLE 168. LATIN AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 169. LATIN AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 170. LATIN AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 171. LATIN AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 172. LATIN AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 173. LATIN AMERICA SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2017-2032 (USD MILLION)
TABLE 174. AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 175. AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 176. AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 177. AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 178. AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 179. AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 180. AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2017-2032 (USD MILLION)
TABLE 181. AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 182. AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2017-2032 (USD MILLION)
TABLE 183. AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2017-2032 (USD MILLION)
TABLE 184. AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 185. AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 186. AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 187. AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 188. AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 189. AFRICA SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2017-2032 (USD MILLION)
TABLE 190. MIDDLE EAST SEPSIS DIAGNOSTIC MARKET SIZE, BY REGION, 2017-2032 (USD MILLION)
TABLE 191. MIDDLE EAST SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 192. MIDDLE EAST SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 193. MIDDLE EAST SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 194. MIDDLE EAST SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 195. MIDDLE EAST SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 196. MIDDLE EAST SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2017-2032 (USD MILLION)
TABLE 197. MIDDLE EAST SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 198. MIDDLE EAST SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2017-2032 (USD MILLION)
TABLE 199. MIDDLE EAST SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2017-2032 (USD MILLION)
TABLE 200. MIDDLE EAST SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 201. MIDDLE EAST SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 202. MIDDLE EAST SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 203. MIDDLE EAST SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 204. MIDDLE EAST SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 205. MIDDLE EAST SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2017-2032 (USD MILLION)
TABLE 206. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 207. NATO SEPSIS DIAGNOSTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 208. NATO SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 209. NATO SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 210. NATO SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 211. NATO SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 212. NATO SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 213. NATO SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2017-2032 (USD MILLION)
TABLE 214. NATO SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 215. NATO SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2017-2032 (USD MILLION)
TABLE 216. NATO SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2017-2032 (USD MILLION)
TABLE 217. NATO SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 218. NATO SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 219. NATO SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 220. NATO SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 221. NATO SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 222. NATO SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2017-2032 (USD MILLION)
TABLE 223. G7 SEPSIS DIAGNOSTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 224. G7 SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 225. G7 SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 226. G7 SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 227. G7 SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 228. G7 SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 229. G7 SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2017-2032 (USD MILLION)
TABLE 230. G7 SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 231. G7 SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2017-2032 (USD MILLION)
TABLE 232. G7 SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2017-2032 (USD MILLION)
TABLE 233. G7 SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 234. G7 SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 235. G7 SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 236. G7 SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 237. G7 SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 238. G7 SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2017-2032 (USD MILLION)
TABLE 239. BRICS SEPSIS DIAGNOSTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 240. BRICS SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 241. BRICS SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 242. BRICS SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 243. BRICS SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 244. BRICS SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 245. BRICS SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2017-2032 (USD MILLION)
TABLE 246. BRICS SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 247. BRICS SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2017-2032 (USD MILLION)
TABLE 248. BRICS SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2017-2032 (USD MILLION)
TABLE 249. BRICS SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 250. BRICS SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 251. BRICS SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 252. BRICS SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 253. BRICS SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 254. BRICS SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2017-2032 (USD MILLION)
TABLE 255. EUROPEAN UNION SEPSIS DIAGNOSTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 256. EUROPEAN UNION SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 257. EUROPEAN UNION SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 258. EUROPEAN UNION SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 259. EUROPEAN UNION SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 260. EUROPEAN UNION SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 261. EUROPEAN UNION SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2017-2032 (USD MILLION)
TABLE 262. EUROPEAN UNION SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 263. EUROPEAN UNION SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2017-2032 (USD MILLION)
TABLE 264. EUROPEAN UNION SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2017-2032 (USD MILLION)
TABLE 265. EUROPEAN UNION SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 266. EUROPEAN UNION SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 267. EUROPEAN UNION SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 268. EUROPEAN UNION SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 269. EUROPEAN UNION SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 270. EUROPEAN UNION SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2017-2032 (USD MILLION)
TABLE 271. ASEAN SEPSIS DIAGNOSTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 272. ASEAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 273. ASEAN SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 274. ASEAN SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 275. ASEAN SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 276. ASEAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 277. ASEAN SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2017-2032 (USD MILLION)
TABLE 278. ASEAN SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 279. ASEAN SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2017-2032 (USD MILLION)
TABLE 280. ASEAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2017-2032 (USD MILLION)
TABLE 281. ASEAN SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 282. ASEAN SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 283. ASEAN SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 284. ASEAN SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 285. ASEAN SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 286. ASEAN SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2017-2032 (USD MILLION)
TABLE 287. GCC SEPSIS DIAGNOSTIC MARKET SIZE, BY GROUP, 2017-2032 (USD MILLION)
TABLE 288. GCC SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 289. GCC SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 290. GCC SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 291. GCC SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 292. GCC SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 293. GCC SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2017-2032 (USD MILLION)
TABLE 294. GCC SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 295. GCC SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2017-2032 (USD MILLION)
TABLE 296. GCC SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2017-2032 (USD MILLION)
TABLE 297. GCC SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 298. GCC SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 299. GCC SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 300. GCC SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 301. GCC SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 302. GCC SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2017-2032 (USD MILLION)
TABLE 303. GLOBAL SEPSIS DIAGNOSTIC MARKET SIZE, BY COUNTRY, 2017-2032 (USD MILLION)
TABLE 304. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 305. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 306. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 307. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 308. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 309. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 310. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2017-2032 (USD MILLION)
TABLE 311. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 312. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2017-2032 (USD MILLION)
TABLE 313. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2017-2032 (USD MILLION)
TABLE 314. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 315. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 316. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 317. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 318. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 319. CHINA SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2017-2032 (USD MILLION)
TABLE 320. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 321. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 322. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 323. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 324. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 325. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 326. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2017-2032 (USD MILLION)
TABLE 327. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 328. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2017-2032 (USD MILLION)
TABLE 329. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2017-2032 (USD MILLION)
TABLE 330. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 331. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 332. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 333. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 334. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 335. UNITED STATES SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2017-2032 (USD MILLION)
TABLE 336. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 337. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 338. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 339. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 340. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 341. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 342. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2017-2032 (USD MILLION)
TABLE 343. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 344. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2017-2032 (USD MILLION)
TABLE 345. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2017-2032 (USD MILLION)
TABLE 346. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 347. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 348. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 349. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 350. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 351. JAPAN SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2017-2032 (USD MILLION)
TABLE 352. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 353. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 354. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 355. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 356. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY SOFTWARE & SERVICES, 2017-2032 (USD MILLION)
TABLE 357. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY TECHNOLOGY, 2017-2032 (USD MILLION)
TABLE 358. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY ELISA, 2017-2032 (USD MILLION)
TABLE 359. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY FLOW CYTOMETRY, 2017-2032 (USD MILLION)
TABLE 360. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY NGS, 2017-2032 (USD MILLION)
TABLE 361. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY PCR, 2017-2032 (USD MILLION)
TABLE 362. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY END USER, 2017-2032 (USD MILLION)
TABLE 363. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY AMBULATORY CARE CENTERS, 2017-2032 (USD MILLION)
TABLE 364. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY DIAGNOSTIC LABORATORIES, 2017-2032 (USD MILLION)
TABLE 365. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY HOSPITALS, 2017-2032 (USD MILLION)
TABLE 366. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY DISTRIBUTION CHANNEL, 2017-2032 (USD MILLION)
TABLE 367. INDIA SEPSIS DIAGNOSTIC MARKET SIZE, BY INDIRECT, 2017-2032 (USD MILLION)
TABLE 368. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, 2017-2032 (USD MILLION)
TABLE 369. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY PRODUCT TYPE, 2017-2032 (USD MILLION)
TABLE 370. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY INSTRUMENTS, 2017-2032 (USD MILLION)
TABLE 371. GERMANY SEPSIS DIAGNOSTIC MARKET SIZE, BY REAGENTS & KITS, 2017-2032 (USD MILLION)
TABLE 372. GERMANY SEPSIS D

Companies Mentioned

  • Abbott Laboratories
  • Alifax S.r.l.
  • Beckman Coulter, Inc.
  • Becton, Dickinson and Company
  • bioMérieux SA
  • Boditech Med Inc.
  • Bruker Corporation
  • CytoSorbents Corporation
  • DiaSorin S.p.A.
  • EKF Diagnostics
  • F. Hoffmann-La Roche AG
  • Immunexpress Inc.
  • Koninklijke Philips N.V.
  • McKesson Corporation
  • Merck KGaA
  • Molzym GmbH & Co. KG
  • Nanomix Inc.
  • Oracle Corporation
  • QIAGEN N.V.
  • Response Biomedical Corporation
  • Seegene Inc.
  • Siemens Healthineers
  • T2 Biosystems
  • Thermo Fisher Scientific, Inc.
  • Wolters Kluwer N.V.

Table Information

Report AttributeDetails
No. of Pages181
PublishedAugust 2026
Forecast Period2026 - 2032
Estimated Market Value ( USD ) in 2026 $ 1.07 Billion
Forecasted Market Value ( USD ) by 2032 $ 1.74 Billion
Compound Annual Growth Rate8.3%
Regions CoveredGlobal
No. of Companies Mentioned25

Related Topics

Related Reports

Sepsis Diagnostics - Global Strategic Business Report - Product Image

Sepsis Diagnostics - Global Strategic Business Report

  • Report
  • 580 Pages
  • Global
From
Sepsis Diagnostics Market Report 2026 - Product Image

Sepsis Diagnostics Market Report 2026

  • Report
  • 250 Pages
  • Global
From
Sepsis Diagnostics Market: 2025 Edition - Product Image

Sepsis Diagnostics Market: 2025 Edition

  • Report
  • 205 Pages
  • Global
From
Sepsis Diagnostics Market 2025-2029 - Global Market Forecasts by Assay, Cause, Product, Lab and Place, with Executive and Consultant Guides - Product Image

Sepsis Diagnostics Market 2025-2029 - Global Market Forecasts by Assay, Cause, Product, Lab and Place, with Executive and Consultant Guides

  • Report
  • 414 Pages
  • Global
From
Sepsis Diagnostics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035 - Product Image

Sepsis Diagnostics Market Opportunity, Growth Drivers, Industry Trend Analysis, and Forecast 2026-2035

  • Report
  • 140 Pages
  • Global
From

About the Sepsis Test Market

The Sepsis Test market is a subset of the Diagnostics industry, focused on the detection and diagnosis of sepsis. Sepsis is a life-threatening condition caused by the body's response to an infection, and early diagnosis is critical for successful treatment. Sepsis tests are used to detect the presence of sepsis-causing bacteria in the blood, and to identify the type of bacteria present. Tests may also be used to monitor the progress of treatment. Sepsis tests are typically performed in a laboratory setting, and may include blood cultures, urine cultures, and other tests. Tests may also be performed using point-of-care devices, which allow for rapid diagnosis in the clinical setting. Companies in the Sepsis Test market include Abbott, Becton Dickinson, bioMérieux, Cepheid, DiaSorin, and Roche. Show Less Read more

Copyright © 2002-2026 Research and Markets. All Rights Reserved.